Abbott Laboratories Seeks FTZ Production Authority for Diagnostic Medical Devices in Texas
August 06, 2026
August 06, 2026
WASHINGTON, Aug. 6 (TNSFR) -- Abbott Laboratories has notified the U.S. Department of Commerce Foreign-Trade Zones Board of its proposed production activity at its facility in Irving, Texas, within Foreign-Trade Zone 39, seeking authority to manufacture a broad range of diagnostic medical devices and related components under Foreign-Trade Zone procedures.
The notification, received by the board on August 3, 2026, was filed under the Foreign-Trade Zones Board's production regula . . .
The notification, received by the board on August 3, 2026, was filed under the Foreign-Trade Zones Board's production regula . . .